Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

erythropoietin drug market Companies

ID: MRFR/Pharma/0852-HCR
85 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Erythropoietin (EPO) drugs companies specialize in the research, development, and manufacturing of medications that contain or mimic erythropoietin, a hormone responsible for stimulating red blood cell production. These drugs are commonly used in the treatment of anemia associated with various conditions, such as chronic kidney disease, cancer, and certain medical procedures.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Erythropoietin Drugs Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.68%
2024 Market Size$ 11.74 Billion
2025 Market Size$ 12.88 Billion
2035 Market Size$ 32.45 Billion
Key Players
Amgen
Roche
Johnson & Johnson
Eli Lilly
Pfizer
Novartis
Opportunities
  • Rising Geriatric Population
  • Advancements in Biotechnology
  • Growing Awareness of Anemia Management

Top Industry Leaders in the erythropoietin drug market

Erythropoietin Drug Key Companies
ย 
Latest Erythropoietin Drug Companies Update

Johnson & Johnson Services, Inc. continues to hold a significant market share with its Procritยฎ and Epogenยฎ brands, but faces competition from biosimilars like Amgen's Epoetin Alfa-NX and Teva's Epoetin alfa.

Roche is developing a new erythropoietin drug called Roxifilan for the treatment of anemia in patients with cancer.

Celltrion is expanding its presence in the market with its biosimilar erythropoietin drug Remsimaยฎ, which is approved for the treatment of several conditions, including anemia in cancer patients.

List of erythropoietin drug Key Companies in the Market

โ€ข Hoffmann-La Roche

โ€ข Johnson & Johnson

โ€ข Amgen

โ€ข Kyowa Hakko Kirin

โ€ข Intas Pharmaceuticals

โ€ข Teva Pharmaceutical Industries Ltd.

โ€ข Biocon

โ€ข Emcure Pharmaceuticals

โ€ข Celltrion Inc.

ย 

โ€ข Hospira